Research Roundup

This week’s research roundup features a study on in Patients with membranous lupus nephritis, exostosin-positivity and exostosin-negativity that represent two different phenotypes.

This week’s research roundup features a study on circulating markers of NADH-reductive stress correlate with mitochondrial disease severity.

This week’s research roundup features a study on CD10 (Neprilysin) Expression: A potential adjunct in the sistinction of hibernoma from morphologic mimics.

This week’s research roundup features a study on changing paradigms in diagnosis and treatment of monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM).

This week’s research roundup features a study on the IFCC clinical application of cardiac biomarkers committee's appraisal of the 2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: getting cardiac troponin right.

This week’s research roundup features a study on improving accuracy of myasthenia gravis autoantibody testing by reflex algorithm.

This week’s research roundup features a study on systematic review and meta-analysis of local salvage therapies after radiotherapy for prostate cancer.

This week’s research roundup features a study on how lewy body disease is a contributor to logopenic progressive aphasia phenotype.

This week’s research roundup features a study on iron heterogeneity in early active multiple sclerosis lesions.

This week’s research roundup features a study on the discovery of rare variants associated with blood pressure regulation through meta-analysis of 1.3 million individuals.

This week’s research roundup features a study on the regulation of direct adipose tissue free fatty acid storage during mixed meal ingestion and high free fatty acid concentration conditions.

This week’s research roundup features a study on grading chromophobe renal cell carcinoma: evidence for a four-tiered classification incorporating coagulative tumor necrosis.

This week’s research roundup features a study on how CRM1 inhibitor anti-tumor activity is enhanced with salicylates by S-phase arrest and impaired DNA-damage repair.